|
Platelet function inhibitors
Citations 201-210 of 251 total displayed.
|
Past content
(since Oct 2000):
|
- Clinical Investigations and Reports
Impact of Clinical Syndrome Acuity on the Differential Response to 2 Glycoprotein IIb/IIIa Inhibitors in Patients Undergoing Coronary Stenting: The TARGET Trial*
- Gregg W. Stone, David J. Moliterno, Michel Bertrand, Franz-Josef Neumann, Howard C. Herrmann, Eric R. Powers, Cindy L. Grines, Jeffrey W. Moses, David J. Cohen, Eric A. Cohen, Marc Cohen, Kathy Wolski, Peter M. DiBattiste, and Eric J. Topol
Circulation 2002;105:2347-2354; published online before print as doi:10.1161/01.CIR.0000017635.82128.8C
[Abstract]
[Full text]
- Clinical Investigations and Reports
Benefits and Safety of Tirofiban Among Acute Coronary Syndrome Patients With Mild to Moderate Renal Insufficiency: Results From the Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) Trial
- James L. Januzzi, Jr, Steven M. Snapinn, Peter M. DiBattiste, Ik-Kyung Jang, and Pierre Theroux
Circulation 2002;105:2361-2366; published online before print as doi:10.1161/01.CIR.0000016359.94919.16
[Abstract]
[Full text]
- Articles
Impact of Different Platelet
Glycoprotein IIb/IIIa Receptor Inhibitors Among
Diabetic Patients Undergoing Percutaneous
Coronary Intervention. Do Tirofiban and ReoPro Give Similar
Efficacy Outcomes Trial (TARGET) 1-Year Follow-Up
- Marco Roffi, David J. Moliterno, Bernhard Meier, Eric R. Powers, Cindy L. Grines, Peter M. DiBattiste, Howard C. Herrmann, Michel Bertrand, Katherine E. Harris, Laura A. Demopoulos, Eric J. Topol for the TARGET
Investigators
Circulation published May 13, 2002, doi:10.1161/01.CIR.0000018123.02672.C7
[Abstract]
- Clinical Cardiology: New Frontiers
New Therapeutic Options in Congestive Heart Failure: Part II
- John McMurray and Marc A. Pfeffer
Circulation 2002;105:2223-2228, doi:10.1161/01.CIR.0000014771.38666.22
[Full text]
- Articles
Functional Significance of Adenosine
5'-Diphosphate Receptor (P2Y12) in
Platelet Activation Initiated by Binding of von Willebrand
Factor to Platelet GP Ib Induced by Conditions of High Shear
Rate
- Shinya Goto, Noriko Tamura, Koji Eto, Yasuo Ikeda, and Shunnosuke Handa
Circulation published April 29, 2002, doi:10.1161/01.CIR.0000016703.93845.AF
[Abstract]
- Articles
Benefits and Safety of Tirofiban Among Acute
Coronary Syndrome Patients With Mild to Moderate Renal
Insufficiency. Results From the Platelet Receptor
Inhibition in Ischemic Syndrome Management in Patients Limited
by Unstable Signs and Symptoms (PRISM-PLUS)
Trial.
- James L. Januzzi, Jr, Steven M. Snapinn, Peter M. DiBattiste, Ik-Kyung Jang, and Pierre Theroux
Circulation published April 29, 2002, doi:10.1161/01.CIR.0000016359.94919.16
[Abstract]
- Basic Science Reports
Comparative Antithrombotic Effects of Magnesium Sulfate and the Platelet Glycoprotein IIb/IIIa Inhibitors Tirofiban and Eptifibatide in a Canine Model of Stent Thrombosis
- Vladimir Rukshin, Prediman K. Shah, Bojan Cercek, Ariel Finkelstein, Vivian Tsang, and Sanjay Kaul
Circulation 2002;105:1970-1975; published online before print as doi:10.1161/01.CIR.0000014612.88433.62
[Abstract]
[Full text]
- Clinical Investigations and Reports
Impact of Clinical Syndrome Acuity on the Differential Response to 2 Glycoprotein IIb/IIIa Inhibitors in Patients Undergoing Coronary Stenting: The TARGET Trial*
- Gregg W. Stone, David J. Moliterno, Michel Bertrand, Franz-Josef Neumann, Howard C. Herrmann, Eric R. Powers, Cindy L. Grines, Jeffrey W. Moses, David J. Cohen, Eric A. Cohen, Marc Cohen, Kathy Wolski, Peter M. DiBattiste, and Eric J. Topol
Circulation published April 22, 2002, doi:10.1161/01.CIR.0000017635.82128.8C
[Abstract]
[Full text]
- Clinical Investigations and Reports
Aspirin-Resistant Thromboxane Biosynthesis and the Risk of Myocardial Infarction, Stroke, or Cardiovascular Death in Patients at High Risk for Cardiovascular Events
- John W. Eikelboom, Jack Hirsh, Jeffrey I. Weitz, Marilyn Johnston, Qilong Yi, and Salim Yusuf
Circulation 2002;105:1650-1655; published online before print as doi:10.1161/01.CIR.0000013777.21160.07
[Abstract]
[Full text]
- Articles
Comparative Antithrombotic Effects of Magnesium
Sulfate and the Platelet Glycoprotein IIb/IIIa
Inhibitors Tirofiban and Eptifibatide in a Canine Model of
Stent Thrombosis
- Vladimir Rukshin, Prediman K. Shah, Bojan Cercek, Ariel Finkelstein, Vivian Tsang, and Sanjay Kaul
Circulation published April 8, 2002, doi:10.1161/01.CIR.0000014612.88433.62
[Abstract]
|
|
